These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31859980)

  • 21. Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients.
    Fehr M; Müller J; Knitel M; Fornaro J; Horber D; Koeberle D; Cerny T; Güller U
    Clin Colorectal Cancer; 2017 Dec; 16(4):343-348. PubMed ID: 28412138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synchronous second primary neoplasms detected by initial staging F-18 FDG PET/CT examination in patients with non-Hodgkin lymphoma.
    Papajík T; Mysliveček M; Sedová Z; Buriánková E; Procházka V; Raida L; Kubová Z; Neoral C; Starostka D; Mikula P; Melichar B; Kučerová L; Tichý M; Indrák K
    Clin Nucl Med; 2011 Jul; 36(7):509-12. PubMed ID: 21637049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET/CT colonography for the preoperative evaluation of the colon proximal to the obstructive colorectal cancer.
    Nagata K; Ota Y; Okawa T; Endo S; Kudo SE
    Dis Colon Rectum; 2008 Jun; 51(6):882-90. PubMed ID: 18330647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
    Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
    Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of preoperative CT colonography in patients with colorectal cancer.
    Sali L; Falchini M; Taddei A; Mascalchi M
    World J Gastroenterol; 2014 Apr; 20(14):3795-803. PubMed ID: 24744573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
    Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
    Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (18)F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management.
    Malik V; Johnston C; Donohoe C; Claxton Z; Lucey J; Ravi N; Reynolds JV
    Clin Nucl Med; 2012 Dec; 37(12):1152-8. PubMed ID: 23154472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
    Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synchronous Double Primary Malignant Tumors and their Possible Shared Genes: A Rare Clinical Entity.
    Hu N; Yan G; Tang MW; Wu YH; Xiang YN; Lei PG
    Curr Med Imaging; 2024; 20():e15734056258908. PubMed ID: 38087432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin.
    De Vos N; Goethals I; Ceelen W
    Acta Chir Belg; 2014; 114(6):370-5. PubMed ID: 26021680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers.
    Ilcheva M; Nikolova P; Hadzhiyska V; Mladenov K
    Neoplasma; 2022 Jul; 69(4):948-956. PubMed ID: 35471980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer.
    van Westreenen HL; Westerterp M; Jager PL; van Dullemen HM; Sloof GW; Comans EF; van Lanschot JJ; Wiggers T; Plukker JT
    J Nucl Med; 2005 Aug; 46(8):1321-5. PubMed ID: 16085589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rare presentation of primary synchronous renal tract tumours on (18F)- fluorodeoxyglucose positron emission tomography- computed tomography.
    Ahmad W; Gill SM; Hassan A
    J Pak Med Assoc; 2020 May; 70(5):942-943. PubMed ID: 32400761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography.
    Ogunbiyi OA; Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Birnbaum EH; Fleshman JW; Read TE; Philpott GW; Kodner IJ
    Ann Surg Oncol; 1997 Dec; 4(8):613-20. PubMed ID: 9416407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: technical feasibility and first experiences in patients with colorectal cancer.
    Veit P; Kühle C; Beyer T; Kuehl H; Herborn CU; Börsch G; Stergar H; Barkhausen J; Bockisch A; Antoch G
    Gut; 2006 Jan; 55(1):68-73. PubMed ID: 15970580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence.
    Makis W; Kurzencwyg D; Hickeson M
    Clin Imaging; 2013; 37(6):1094-7. PubMed ID: 23993799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness.
    Heinrich S; Goerres GW; Schäfer M; Sagmeister M; Bauerfeind P; Pestalozzi BC; Hany TF; von Schulthess GK; Clavien PA
    Ann Surg; 2005 Aug; 242(2):235-43. PubMed ID: 16041214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.